(HealthDay News) — Blacks, Hispanics, women, seniors on Medicare, and patients in rural areas are less likely to be treated with tissue plasminogen activator (tPA) after stroke, according to research ...
August 18, 2006 — Researchers report that initial safety data from the Argatroban tPA Stroke Study, a dose-escalation study of the combination of intravenous tissue plasminogen activator (tPA) and low ...
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
About 87 percent of all strokes are ischemic, meaning they’re caused by a blood clot in the brain. For more than 20 years, the standard of care has been a drug called TPA. But now, some doctors are ...
SAN DIEGO, California — If tissue plasminogen activator (tPA) can be shown to be effective in mild stroke in large-scale trials, it will provide good economic value to the healthcare system, a new ...
Mann draws attention to 2 important points: (1) stroke outcome depends heavily on initial stroke severity as measured by the National Institutes of Health Stroke Scale (NIHSS), and (2) baseline ...
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both ...
Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
AHA: Thrombolysis Shows Potential After Wake-Up Stroke The use of intravenous tissue plasminogen activator (IV tPA) in acute ischemic stroke (AIS) patients nearly doubled from 2003-2011. (HealthDay ...
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback